Are regenerative medicine and stem cells legal in Taiwan? Key points of the 2024 two regenerative laws at a glance
Taiwan's regenerative medicine regulations underwent important legislation in 2024: the Regenerative Medicine Act and the Regenerative Medicine Preparations Act (collectively the two regenerative laws) were promulgated and implemented on June 19, 2024, establishing a framework for the definition, licensing, advertising management, and inspection of regenerative medicine. Prior to this, the MOHW opened specific autologous cell therapies under the Special Regulations on Medical Techniques effective from 2018, allowing approved institutions to perform within the approved scope; after the two laws took effect, they continue to apply and are integrated. The Taiwan Food and Drug Administration (TFDA) is responsible for the registration of regenerative medicine preparations; the MOHW is responsible for approving institutional qualifications. Verification channels: MOHW 'Cell Therapy Technology Information Zone' (celltherapy.mohw.gov.tw) and the Medical Affairs Management System (ma.mohw.gov.tw). This site provides neutral information and does not constitute medical advice.
Key Points of the 2024 Regenerative Dual Laws
Taiwan completed important legislation on regenerative medicine in 2024, establishing a more comprehensive management framework:
- The Regenerative Medicine Act and the Regenerative Medicine Preparations Act (Regenerative Dual Laws) were promulgated on June 19, 2024
- Regulate the definition of regenerative medicine, institutional licensing, advertising management, and inspection
- The Preparations Act establishes "conditional approval": for those completing Phase II clinical trials with confirmed safety and preliminary efficacy, a conditional time-limited approval of no more than 5 years may be granted
How to Confirm a Clinic's Legitimacy
Two official channels for cross-verification; if no approval is found, proceed with caution:
- Ministry of Health and Welfare's "Cell Therapy Technology Information Zone" (celltherapy.mohw.gov.tw): check approved institutions, technology types, and indications
- Ministry of Health and Welfare's Medical Affairs Management System (ma.mohw.gov.tw): check institution business registration
- If performing regenerative medicine, both the institution and the technology must be approved by the competent authority
Advertising and Consumer Protection
The Regenerative Medicine Act has clear regulations on promotion; exaggerated ads can be verified and reported:
- False or exaggerated claims (e.g., claiming "no side effects" without approval) are prohibited; violations may be penalized by law
- When encountering regenerative medicine ads, cross-check with Ministry of Health and Welfare's approved information
- Suspicious false claims can be reported to local health bureaus
FAQ
What is the regulatory framework for regenerative medicine in Taiwan? What changed in 2024?
The main regulatory framework in Taiwan includes: ① Regenerative Medicine Act (promulgated and implemented on June 19, 2024): regulates the definition, institutional licensing, advertising management, and inspection of regenerative medicine; ② Regenerative Medicine Preparations Act (promulgated on the same day): registration and post-market surveillance of regenerative medicine preparations; ③ Special Regulations on Medical Techniques (effective from 2018): specific autologous cell therapies are subject to an approval and licensing system, which continues to apply after the two laws took effect. The TFDA is responsible for preparation registration, and the MOHW is responsible for approving institutional qualifications for implementation (Source: National Laws and Regulations Database, Ministry of Health and Welfare).
How to confirm whether a clinic's regenerative medicine is legally approved?
There are two main official channels for verification: ① Ministry of Health and Welfare's "Cell Therapy Technology Information Zone" (celltherapy.mohw.gov.tw): lists approved institutions, technology types, and indications; ② Ministry of Health and Welfare's Medical Affairs Management System (ma.mohw.gov.tw): check the business registration of medical institutions. If performing regenerative medicine regulated by the Regenerative Medicine Act, both the institution and the technology must be approved by the competent authority. If no approval record is found, careful evaluation is advised.
What are the regulations on advertising and promotion under the Regenerative Medicine Act?
The Regenerative Medicine Act regulates the content of regenerative medicine advertisements, prohibiting false statements or exaggerated claims (e.g., claiming "no side effects" without approval). Violators may be penalized according to law. When encountering regenerative medicine advertisements, consumers can cross-check with the Ministry of Health and Welfare's approved information and report suspicious false claims to local health bureaus (source: relevant provisions of the Regenerative Medicine Act).
How to evaluate the scientific basis of stem cell anti-aging, NAD+ drips, and exosomes?
The level of scientific evidence varies among therapies; some are under research, while others have conditional approval. Stem cell therapy, due to its complex preparation, has had case reports of serious adverse events such as infections and tumors from unregulated treatments internationally. When evaluating, confirm the institution's approval status and physician qualifications, and have a qualified physician fully explain the indications, risks, and alternatives before deciding. Do not rely solely on advertising claims.
Where can I look up official regenerative medicine regulations and approved institutions?
References: ① National Laws and Regulations Database (law.moj.gov.tw) for the Regenerative Medicine Act and the Special Management Regulations; ② Ministry of Health and Welfare's "Cell Therapy Technology Information Zone" (celltherapy.mohw.gov.tw) for approved institutions and plans; ③ Ministry of Health and Welfare's Medical Affairs Management System (ma.mohw.gov.tw) to confirm institution business registration. This site provides neutral information; actual regulations are subject to the latest announcements by the competent authority.
This page is a neutral compilation of information for reference only, not medical advice, and does not constitute any diagnostic commitment.